Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis

  • Yen-Hou Chang (Contributor)
  • Wai-Hou Li (Contributor)
  • Yi Chang (Contributor)
  • Chia-Wen Peng (Contributor)
  • Ching-Hsuan Cheng (Contributor)
  • Wei Pin Chang (Contributor)
  • Chi Mu Chuang (Contributor)



Dataset for computing competing risks. (CSV 18Â kb)
Date made availableJan 1 2016
PublisherUnknown Publisher

Cite this